Diagnosis and Treatment of HCC Varies by Race - Diverse Health

Higher Education News and Jobs

Diagnosis and Treatment of HCC Varies by Race


by Diana Swift

A large retrospective study of hepatocellular (HCC) patients in Texas found racial and ethnic differences in outcomes, with blacks and Hispanics less likely than whites to get early diagnosis and curative treatment, and blacks less likely to survive.

“Our findings have important implications for health policy and highlight the need for further study on racial-ethnic disparities in HCC, including identification of additional actionable intervention,” wrote Amit Singal, MD, MS, of the University of Texas (UT) Southwestern Medical Center’s Simmons Cancer in Dallas, and colleagues in Clinical Gastroenterology and Hepatology.

Read More


Print Friendly